Source wikepedia. This was determined in Jan 2016.
We have provided the states with 35 million vaccines and current distribution production of 1.5 million vaccines destined to states.
At current rates more than 75 million doses of serum will be given the states by March 1st.
At a rate of 50 million doses a month. By decembet of 2021 everyone who wants a vaccine will have access to the drug.
The next drug to be approved is Johnson and Johnson 70 percent effect rate to the original virus 56 percent to mutation of south African and Brazil strains.
However it diminishes mortality from infection to 0.1 % of all infected. Boosting the immune system response.
The current pace can possibly be accelerated by the one dose drug.
The current stradegy is to inoculate those at most risk to death. Then most likely to be infected and spread the disease. Ie essential workers.
Then everyone else over 12 years .
The avg infections after the holiday surge has diminished slowly to roughly half as many new infections as there were a week after Christmas
We are winning this war. As the new administration policies to drive production and inoculation . To the worst hit areas.
More than a person dies every minute from covid eclipsing all other causes of death.
It in time this will be abated to what Ebola levels look like today
0
To remove first post, remove entire topic.
there are 50 million
Americans over the age of 65 residing in America.
Source wikepedia. This was determined in Jan 2016.
We have provided the states with 35 million vaccines and current distribution production of 1.5 million vaccines destined to states.
At current rates more than 75 million doses of serum will be given the states by March 1st.
At a rate of 50 million doses a month. By decembet of 2021 everyone who wants a vaccine will have access to the drug.
The next drug to be approved is Johnson and Johnson 70 percent effect rate to the original virus 56 percent to mutation of south African and Brazil strains.
However it diminishes mortality from infection to 0.1 % of all infected. Boosting the immune system response.
The current pace can possibly be accelerated by the one dose drug.
The current stradegy is to inoculate those at most risk to death. Then most likely to be infected and spread the disease. Ie essential workers.
Then everyone else over 12 years .
The avg infections after the holiday surge has diminished slowly to roughly half as many new infections as there were a week after Christmas
We are winning this war. As the new administration policies to drive production and inoculation . To the worst hit areas.
More than a person dies every minute from covid eclipsing all other causes of death.
It in time this will be abated to what Ebola levels look like today
The Path to Immunity in the U.S. In the U.S., the latest vaccination rate is 1,339,525 doses per day, on average. At this rate, it will take an estimated 11 months to cover 75% of the population with a two-dose vaccine.
Source Bloomberg
0
The Path to Immunity in the U.S. In the U.S., the latest vaccination rate is 1,339,525 doses per day, on average. At this rate, it will take an estimated 11 months to cover 75% of the population with a two-dose vaccine.
If you choose to make use of any information on this website including online sports betting services from any websites that may be featured on
this website, we strongly recommend that you carefully check your local laws before doing so.It is your sole responsibility to understand your local laws and observe them strictly.Covers does not provide
any advice or guidance as to the legality of online sports betting or other online gambling activities within your jurisdiction and you are responsible for complying with laws that are applicable to you in
your relevant locality.Covers disclaims all liability associated with your use of this website and use of any information contained on it.As a condition of using this website, you agree to hold the owner
of this website harmless from any claims arising from your use of any services on any third party website that may be featured by Covers.